The Akkermansia Company
The Akkermansia Company is a Belgium-based microbiome nutrition company that commercializes EFSA-approved pasteurized Akkermansia muciniphila MucT dietary supplements for gut barrier, weight management, and metabolic health via D2C subscriptions and a healthcare professional channel, acquired by Danone in June 2025.
- Company typePrivate
- Founded2021
- HeadquartersMont-saint-guibert, Belgium
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What The Akkermansia Company does
The Akkermansia Company (TAC) is a Belgium-based microbiome nutrition company that develops and commercializes dietary supplements built around its proprietary pasteurized Akkermansia muciniphila MucT strain — a postbiotic form of a commensal gut bacterium originally isolated in 2004 at Wageningen University. The company was co-founded by the strain's scientific discoverers, Prof. Willem M. de Vos (Chief Technology Officer) and Prof. Patrice D. Cani, and holds broad patents covering the Akkermansia species and the pasteurized MucT variant. Akkermansia muciniphila MucT is the only form of the bacterium approved by the European Food Safety Authority (EFSA) for use as a dietary supplement and in foods in Europe, providing a regulatory and IP-backed moat.
The product portfolio consists of two formulations sold in consumer and healthcare professional variants: Akkermansia Essential (30 Billion CFU pasteurized MucT) for gut barrier integrity, weight maintenance, and insulin function; and Healthy Weight with Glucose Control, which combines MucT with chromium, EGCG green tea extract, vitamin B2, and vitamin D3 for targeted metabolic support. The company generates revenue through a subscription-based direct-to-consumer e-commerce channel (Shopify storefront, $44.85-$65/month per subscriber) and a parallel healthcare professional channel distributing professional-grade case packs (12 one-month packs) via the Fullscript platform. In June 2025, TAC was acquired by Danone, integrating the MucT strain and brand into Danone's gut health and next-generation biotic strategy.
The Akkermansia Company firmographics
Firmographics- Name
- The Akkermansia Company
- Legal name
- The Akkermansia Company
- Website
- https://theakkermansiacompany.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- The Akkermansia Company is a Belgium-based microbiome nutrition company that commercializes EFSA-approved pasteurized Akkermansia muciniphila MucT dietary supplements for gut barrier, weight management, and metabolic health via D2C subscriptions and a healthcare professional channel, acquired by Danone in June 2025.
- Ownership category
- akta.pro rank
The Akkermansia Company industry classification
Industry- Product category
- Dietary Supplements
- NAICS
- Food (Health) Supplement Retailers (456191)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
Keywords
Where The Akkermansia Company is headquartered
LocationHeadquarters
- HQ city
- Mont-saint-guibert
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
The Akkermansia Company business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel
Revenue model
- Direct Consumer Supplement Sales: The company generates revenue through direct-to-consumer sales of two main dietary supplement products: Akkermansia Essential and Healthy Weight with Glucose Control. Products are sold through e-commerce subscriptions with monthly or quarterly billing options.
- Healthcare Professional Sales: Sales to healthcare practitioners through professional accounts and the Fullscript platform, with products sold in case quantities (12 one-month packs) at professional pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Akkermansia Essential - One-time purchase |
| Subscription | Quarterly | Akkermansia Essential - 3-Month Subscription |
| Subscription | Monthly | Akkermansia Essential - 1-Month Subscription |
| Subscription | Monthly | Healthy Weight with Glucose Control |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
The Akkermansia Company product offering
Product offeringCore offering
The Akkermansia Company develops and sells dietary supplements based on its proprietary pasteurized Akkermansia muciniphila MucT strain, a next-generation postbiotic targeting gut barrier integrity, weight management, and metabolic health. Its product portfolio includes Akkermansia Essential (core MucT formulation) and Healthy Weight with Glucose Control (MucT combined with chromium, EGCG green tea extract, and vitamins B2 and D3), each available in consumer and healthcare professional versions.
Product overview
The Akkermansia Company offers a focused portfolio of dietary supplements centered around its proprietary pasteurized Akkermansia muciniphila MucT strain—a clinically studied postbiotic for gut barrier integrity and metabolic health. The product line consists of four offerings: Akkermansia Essential (consumer and professional versions) providing the core 30 Billion CFU MucT formulation for general gut health, weight maintenance, and insulin function; and Healthy Weight with Glucose Control (consumer and professional versions) combining MucT with additional ingredients (chromium, EGCG green tea, vitamins B2 and D3) for targeted weight management and metabolic support. Both products are available in consumer retail and healthcare professional formulations, with the professional versions sold in bulk cases.
Differentiator
Problem solved
Functional benefit
Products and services
- Akkermansia Essential (Consumer) Dietary supplement containing 30 Billion CFU of pasteurized Akkermansia muciniphila MucT for weight maintenance, gut barrier protection, insulin function, immune function, and antioxidant defense. Sold direct-to-consumer through the company's Shopify website with monthly or quarterly subscription options.
- Akkermansia Essential (Professional) Healthcare practitioner-specific version of Akkermansia Essential supplement sold as a case of 12 one-month packs containing the same pasteurized Akkermansia muciniphila MucT formulation. Distributed to licensed healthcare providers through the Fullscript platform at professional pricing.
- Healthy Weight with Glucose Control (Consumer) Dietary supplement combining pasteurized Akkermansia muciniphila MucT with chromium, EGCG green tea extract, vitamin B2, and vitamin D3 to support weight management, intestinal barrier function, healthy inflammatory response, and glucose metabolism. Sold direct-to-consumer via subscription.
- Healthy Weight with Glucose Control (Professional) Healthcare practitioner-specific version of Healthy Weight with Glucose Control supplement with the same formulation of Akkermansia muciniphila MucT, chromium, EGCG, and vitamins. Sold in bulk to licensed healthcare providers through professional accounts and the Fullscript catalog.
Quantifiable outcome
- Weight regain reduced to 1.2kg vs 3.2kg placebo during maintenance phase (P=0.012)
- +6 more outcomes
Companies that use The Akkermansia Company
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
The Akkermansia Company technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
The Akkermansia Company partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- University of CopenhagencoreAcademic research partner in the clinical trial published in Nature Medicine (May 2026) on pasteurized Akkermansia muciniphila MucT for weight loss maintenance.
- Wageningen University & ResearchcoreAcademic partner where co-founder Prof. Willem M. de Vos served as Chair of Microbiology for over 25 years. Partner in clinical research on Akkermansia muciniphila MucT.
- Maastricht University Medical Center+coreAcademic research partner that conducted the randomized controlled trial published in Nature Medicine demonstrating MucT's effectiveness for weight loss maintenance. Part of the consortium with University of Copenhagen and Wageningen University.
- FullscriptminorHealthcare professional distribution platform through which The Akkermansia Company sells professional-grade products to licensed healthcare practitioners.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
The Akkermansia Company competitors and assessment
Company assessmentDirect peers
- Viome: Viome pairs gut microbiome testing with personalized nutrition recommendations and supplements. It overlaps with The Akkermansia Company on gut health diagnostics-adjacent wellness, premium DTC positioning, and subscription revenue.
- Ritual: Ritual is a premium DTC supplement brand with a subscription model, science-forward branding, and clinically-backed formulations. It competes for the same health-conscious, educated supplement consumer with similar messaging architecture.
- Athletic Greens (AG1): AG1 is a premium DTC daily nutritional supplement sold via subscription at a comparable price point to Akkermansia Essential. It competes for the same health-conscious consumer wallet share with gut-health-adjacent claims.
- Seed Health: Seed is a premium DTC microbiome brand selling scientifically-formulated probiotic and prebiotic subscriptions. It targets similar gut health and metabolic wellness consumers with subscription-based pricing and clinical positioning.
- Care/of: Care/of is a personalized DTC vitamin and supplement subscription brand competing for the same premium, wellness-oriented consumer segment with a subscription e-commerce model.
- Pendulum Therapeutics: Pendulum is the most direct competitor — it sells a probiotic containing a live Akkermansia muciniphila strain (and other strains) targeting metabolic health and glucose control, overlapping directly with The Akkermansia Company's MucT-based formulations.
Broad incumbents
- Culturelle: Culturelle is one of the largest mass-market probiotic brands (Lactobacillus rhamnosus GG). It is a broad incumbent in the digestive health category where The Akkermansia Company competes, with substantially broader retail distribution.
- Yakult: Yakult is a globally established probiotic functional-food brand (Lactobacillus casei strain Shirota). It competes in the broader gut health category via retail distribution and is a potential benchmark for the functional-food expansion path of Akkermansia MucT.
Others
- Novonesis (formerly Novozymes / Chr. Hansen): Novonesis is a global B2B supplier of probiotic, enzyme, and postbiotic ingredients used by supplement and food manufacturers. It is relevant as an enabling supplier in the microbiome value chain that The Akkermansia Company ultimately depends on for downstream scale.
Emerging players
- BIOHM Health: BIOHM develops microbiome-focused supplements addressing gut and oral mycobiome, positioned at the intersection of probiotics and functional nutrition — comparable to The Akkermansia Company's gut barrier and metabolic focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
The Akkermansia Company social profiles
Digital presenceThe Akkermansia Company financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Akkermansia Company leadership team
Management profileNumber of profiles
Profiles3 records
The Akkermansia Company funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Akkermansia Company M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Akkermansia Company
What does The Akkermansia Company do?
The Akkermansia Company develops and sells dietary supplements based on its proprietary pasteurized Akkermansia muciniphila MucT strain, a next-generation postbiotic targeting gut barrier integrity, weight management, and metabolic health. Its product portfolio includes Akkermansia Essential (core MucT formulation) and Healthy Weight with Glucose Control (MucT combined with chromium, EGCG green tea extract, and vitamins B2 and D3), each available in consumer and healthcare professional versions.
Is The Akkermansia Company a public or private company?
The Akkermansia Company is a private company. It is classified as corporate owned and is currently acquired.
When was The Akkermansia Company founded?
The Akkermansia Company was founded in 2021. It employs 11 to 50 people.
Where is The Akkermansia Company based?
The Akkermansia Company is headquartered in Mont-saint-guibert, Belgium, in the Europe region.
How does The Akkermansia Company make money?
Two revenue lines are on record. Direct Consumer Supplement Sales are the primary driver. The others are healthcare Professional Sales.
Who are The Akkermansia Company's main competitors?
Direct peers on record are Viome, Ritual, Athletic Greens (AG1), Seed Health, Care/of and Pendulum Therapeutics. Broad incumbents are Culturelle and Yakult. Novonesis (formerly Novozymes / Chr. Hansen) is listed as an others. BIOHM Health is listed as an emerging player.
Does The Akkermansia Company have an API?
No public API is recorded for The Akkermansia Company.
What industry is The Akkermansia Company in?
The Akkermansia Company's product category is Dietary Supplements. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 456191 and its SIC code is 2000.